(Total Views: 654)
Posted On: 08/29/2018 4:54:34 PM
Post# of 33
ALRT - Post from a member on another board.
ALRT updated DD package as of 8-27-18: : :
Current Share Structure
Issued: 242,777,909
Restricted: 152,776,740
Float: 90,001,169
(There is no dilution)
ALRT is fully SEC reporting and compliant, the below three PRs explain a great deal about the company.
5-14-18 PR. This sets the stage for the past few years, marketing to a handful of COUNTRIES! Check out the youtube video on how it works
https://globenewswire.com/news-release/2018/0...Scale.html
6-28-18 PR. Very important detail that they can now be billed to insurers!
https://globenewswire.com/news-release/2018/0...ution.html
8-27-18 PR. ALRT is launching in India with an estimated 100 million diabetes patients!
https://globenewswire.com/news-release/2018/0...India.html
The marketing plan is to generate $5-$10 in revenue per patient using the system per month. This is from a combination of charges for the system, and other revenue they can get by linking up with suppliers and the like. $10 times 1,000,000 patients times 12 months would be $120,000,000 a year with 1% market penetration in India. That is just one launch, they are working on initiatives across the globe!
The CEO has financed the company himself to the tune of $15,000,000+. If that doesn't speak to where this company is going I don't know what can. He would not be able to get even a fraction back through dilution, the only way he gets repaid (and makes money) is through revenue and success.
ALRT updated DD package as of 8-27-18: : :
Current Share Structure
Issued: 242,777,909
Restricted: 152,776,740
Float: 90,001,169
(There is no dilution)
ALRT is fully SEC reporting and compliant, the below three PRs explain a great deal about the company.
5-14-18 PR. This sets the stage for the past few years, marketing to a handful of COUNTRIES! Check out the youtube video on how it works
https://globenewswire.com/news-release/2018/0...Scale.html
6-28-18 PR. Very important detail that they can now be billed to insurers!
https://globenewswire.com/news-release/2018/0...ution.html
8-27-18 PR. ALRT is launching in India with an estimated 100 million diabetes patients!
https://globenewswire.com/news-release/2018/0...India.html
The marketing plan is to generate $5-$10 in revenue per patient using the system per month. This is from a combination of charges for the system, and other revenue they can get by linking up with suppliers and the like. $10 times 1,000,000 patients times 12 months would be $120,000,000 a year with 1% market penetration in India. That is just one launch, they are working on initiatives across the globe!
The CEO has financed the company himself to the tune of $15,000,000+. If that doesn't speak to where this company is going I don't know what can. He would not be able to get even a fraction back through dilution, the only way he gets repaid (and makes money) is through revenue and success.
(0)
(0)
